Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical Outcome
Martine E.D. Chamuleau(Dutch Cancer Society), Gert J. Ossenkoppele(Amsterdam UMC Location Vrije Universiteit Amsterdam), Arjan A. van de Loosdrecht(Amsterdam UMC Location Vrije Universiteit Amsterdam), S. Marieke van Ham(Sanquin), Theresia M. Westers(Vrije Universiteit Amsterdam), Chris J.L.M. Meijer(Amsterdam UMC Location VUmc), Adri Zevenbergen(Amsterdam UMC Location VUmc), Yuri Souwer(The Netherlands Cancer Institute), Johannes Berkhof
Cited by 63
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k